Holen Sie sich die Stockscreener-App
1.49
0.67%
-0.01
Handel nachbörslich:
1.47
-0.02
-1.34%
Schlusskurs vom Vortag:
$1.50
Offen:
$1.52
24-Stunden-Volumen:
136.45K
Relative Volume:
0.85
Marktkapitalisierung:
$46.48M
Einnahmen:
$81,000
Nettoeinkommen (Verlust:
$-41.04M
KGV:
-1.1314
EPS:
-1.3169
Netto-Cashflow:
$-30.69M
1W Leistung:
-5.70%
1M Leistung:
-7.45%
6M Leistung:
+29.57%
1J Leistung:
-8.59%
1-Tages-Spanne:
$1.48
$1.53
1-Wochen-Bereich:
$1.48
$1.6199
52-Wochen-Spanne:
$1.06
$2.41
Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
Firmenname
Actinium Pharmaceuticals Inc
Sektor
Branche
Telefon
646-767-3870
Adresse
275 Madison Avenue, 7th Floor, New York, NY
Vergleichen Sie ATNM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATNM
Actinium Pharmaceuticals Inc
|
1.49 | 46.79M | 81,000 | -41.04M | -30.69M | -1.3169 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-07 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2024-05-14 | Eingeleitet | Stephens | Overweight |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-02-21 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-09-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-08-25 | Eingeleitet | B. Riley Securities | Buy |
| 2020-11-05 | Eingeleitet | Alliance Global Partners | Buy |
| 2017-12-06 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-10-23 | Fortgesetzt | ROTH Capital | Buy |
| 2017-09-14 | Eingeleitet | Maxim Group | Buy |
| 2016-08-25 | Eingeleitet | ROTH Capital | Buy |
| 2016-02-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-10-15 | Eingeleitet | FBR Capital | Outperform |
| 2014-10-01 | Eingeleitet | MLV & Co | Buy |
| 2014-07-22 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Actinium Pharmaceuticals Inc Aktie (ATNM) Neueste Nachrichten
Can Actinium Pharmaceuticals Inc. recover in the next quarter2025 Risk Factors & Expert Approved Trade Ideas - newser.com
Why Actinium Pharmaceuticals Inc. (7AY1) stock remains stableWeekly Trading Summary & Verified Momentum Watchlists - newser.com
Will Actinium Pharmaceuticals Inc. (Delaware) stock beat international competitionInflation Watch & AI Forecasted Stock Moves - newser.com
Is Actinium Pharmaceuticals Inc. (Delaware) stock a contrarian opportunityJuly 2025 Market Mood & Technical Pattern Recognition Alerts - newser.com
How geopolitical risks impact Actinium Pharmaceuticals Inc. (7AY1) stockSell Signal & High Return Stock Watch Alerts - newser.com
Exit strategy if you’re trapped in Actinium Pharmaceuticals Inc.Market Weekly Review & High Conviction Buy Zone Picks - newser.com
Will Actinium Pharmaceuticals Inc. stock remain a Wall Street favoritePrice Action & Real-Time Volume Trigger Notifications - newser.com
Will Actinium Pharmaceuticals Inc. stock recover faster than marketJuly 2025 Trends & AI Powered Trade Plan Recommendations - newser.com
Short interest data insights for Actinium Pharmaceuticals Inc.IPO Watch & Risk Managed Investment Signals - newser.com
Does Actinium Pharmaceuticals Inc. show high probability of rebound2025 Historical Comparison & Risk Managed Trade Strategies - newser.com
How big funds are accumulating Actinium Pharmaceuticals Inc. (7AY1) stockQuarterly Growth Report & Safe Investment Capital Preservation Plans - newser.com
How Actinium Pharmaceuticals Inc. (7AY1) stock performs in volatility spikesRate Cut & Real-Time Volume Analysis - newser.com
Why Actinium Pharmaceuticals Inc. (Delaware) stock stays undervaluedJuly 2025 Selloffs & Smart Investment Allocation Insights - newser.com
Actinium Pharmaceuticals Inc. stock trend forecast2025 Volume Leaders & AI Forecasted Entry and Exit Points - newser.com
How to use Fibonacci retracement on Actinium Pharmaceuticals Inc.2025 Retail Activity & Safe Capital Growth Tips - newser.com
Published on: 2025-10-01 07:40:56 - newser.com
Is Actinium Pharmaceuticals Inc a good long term investmentTechnical Analysis Insights & Trusted Financial Advisors at No Cost - earlytimes.in
Actinium Pharmaceuticals, Inc. $ATNM Shares Sold by Goldman Sachs Group Inc. - Defense World
What drives Actinium Pharmaceuticals Inc 7AY1 stock priceVolume Analysis Techniques & Small Capital Wealth Plans - earlytimes.in
What drives Actinium Pharmaceuticals Inc stock priceContrarian Investment Ideas & Double Or Triple Capital - earlytimes.in
Finanzdaten der Actinium Pharmaceuticals Inc-Aktie (ATNM)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):